FY2025 · ended Sep 30, 2025 · Revenue $9.10M, +163.5% YoY · Filed Dec 17, 2025
NeuroOne Medical Technologies Corporation (NMTC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $9.1 million and a net loss of $3.6 million. Free cash flow was -$2.9 million. As of Jun 30, 2026 it held $2.0 million in cash and investments and $175,345 in total debt.
Revenue (TTM)
$9.47M
+42.8% vs year-ago TTM
Net income (TTM)
$-7.45M
-39.5% vs year-ago TTM
Operating cash flow (TTM)
$-7.05M
-77.3% vs year-ago TTM
Free cash flow (TTM)
$-7.16M
-75.2% vs year-ago TTM
EPS (TTM)
$-0.18
+59.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
50.43M
+0.0% vs prior year
Net cash
$1.87M
as of Jun 30, 2026
Operating margin
-83.4%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NMTC (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Eden Prairie, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1500198
- Former names
- Original Source Entertainment, Inc. (until May 22, 2017)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
FY 2024 Sep 30, 2024 |
FY 2023 Sep 30, 2023 |
FY 2022 Sep 30, 2022 |
FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $9.1M | $3.5M | $2.0M | $171,169 | $178,146 |
| Operating income | -$4.2M | -$11.9M | -$12.0M | -$10.0M | -$10.2M |
| Net income | -$3.6M | -$12.3M | -$11.9M | -$10.0M | -$9.9M |
| Diluted EPS | -$0.09 | -$0.46 | -$0.65 | -$0.63 | — |
| Operating cash flow | -$2.8M | -$11.0M | -$12.9M | -$7.5M | -$8.6M |
| Free cash flow | -$2.9M | -$11.1M | -$13.3M | -$7.8M | -$8.7M |
| Total assets | $10.8M | $5.4M | $8.1M | $12.8M | $7.9M |
| Total liabilities | $3.7M | $4.5M | $1.8M | $3.2M | $1.4M |
| Stockholders' equity | $7.1M | $822,013 | $6.2M | $9.6M | $6.6M |
| Cash and investments | $6.6M | $1.5M | $5.3M | $11.1M | $6.9M |
| Total debt | $266,806 | $260,160 | $239,684 | $239,112 | $405,790 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Other events
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Other events
|
Aug 27, 2026 | Aug 27, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Jun 12, 2026 | Jun 12, 2026 |
| 10-Q/A | Amended quarterly report | Jun 12, 2026 | Mar 31, 2026 |
All 653 NeuroOne Medical Technologies Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.